1
|
Li W, Ye X, Huang Y, Dong Y, Chen X, Yang Y. An integrated ultrasound imaging and abdominal compression device for respiratory motion management in radiation therapy. Med Phys 2022; 49:6334-6345. [PMID: 35950934 DOI: 10.1002/mp.15928] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2021] [Revised: 07/13/2022] [Accepted: 08/02/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Radiotherapy to tumors in the abdomen is challenging because of the significant organ movement and tissue deformation caused by respiration. PURPOSE A motion management strategy that integrated ultrasound (US) imaging with abdominal compression was developed and evaluated, where US was used to real-time monitor organ motion after abdominal compression. METHODS A device that combined a US imaging system and an abdominal compression plate (ACP) was developed. Twenty-one healthy volunteers were involved to evaluate the motion management efficacy. Each volunteer was immobilized on a flat bench by the device. Abdominal US data were successively collected with and without ACP compression and experiments were repeated three times to verify the imaging reproducibility. A template matching algorithm based on normalized cross correlation (NCC) was implemented to track the targets (vessels in the liver, pancreas and stomach) automatically. The matching algorithm was validated by comparing with the manual references. Automatic tracking was judged as failed if the center of mass difference from manual tracking was beyond a failure threshold. Based on the locations obtained through the template matching algorithm, the motion correlation between liver and pancreas/stomach was investigated using Pearson correlation test. Paired Student's t-test was used to analyze the difference between the results without and with ACP compression. RESULTS The liver motion amplitude over all 21 volunteers was significantly (p<0.001) reduced from 14.9 ± 5.5/3.4 ± 1.8 mm in superior-inferior (SI)/anterior-posterior (AP) direction before ACP compression to 7.3 ± 1.5/1.6 ± 0.7 mm after ACP compression. The mean liver motion standard deviation before compression was on average 2.8/1.4 mm in SI/AP direction, and was significantly (p<0.001) reduced to 0.9/0.4 mm after compression. The failure rates of automatic tracking for liver, pancreas and stomach were reduced for failure thresholds of 1-5 mm after applying ACP. The Pearson correlation coefficients between liver and pancreas/stomach were 0.98/0.97 without ACP and 0.96/0.94 with ACP in SI direction, and were 0.68/0.68 and 0.43/0.42 in AP direction. The motion prediction errors for pancreas/stomach with ACP have significantly (p<0.001) reduced to 0.45 ± 0.36/0.52 ± 0.43 mm from 0.69 ± 0.56/0.71 ± 0.66 mm without ACP in SI direction, and to 0.38 ± 0.33/0.39 ± 0.27 mm from 0.44 ± 0.35/0.61 ± 0.59 mm in AP direction. CONCLUSIONS The proposed strategy that combines real-time US imaging and abdominal compression has the potential to reduce the abdominal organ motion while improving both target tracking reliability and motion reproducibility. Furthermore, the observed correlation between liver and pancreas/stomach motion indicates the possibility of indirect pancreas/stomach tracking using liver markers as tracking surrogates. The strategy is expected to provide an alternative for respiratory motion management in the radiation treatment of abdominal tumors. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Wanqing Li
- Department of Engineering and Applied Physics, University of Science and Technology of China, Hefei, Anhui, 230026, China
| | - Xianjun Ye
- Department of Ultrasound Medicine, the First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, 230001, China
| | - Yunwen Huang
- Department of Radiation Oncology, the First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, 230001, China
| | - Yuyan Dong
- Department of Engineering and Applied Physics, University of Science and Technology of China, Hefei, Anhui, 230026, China
| | - Xuemin Chen
- Health Management Center, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China
| | - Yidong Yang
- Department of Engineering and Applied Physics, University of Science and Technology of China, Hefei, Anhui, 230026, China.,Department of Radiation Oncology, the First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, 230001, China
| |
Collapse
|
2
|
Zhou D, Nakamura M, Mukumoto N, Yoshimura M, Mizowaki T. Development of a deep learning-based patient-specific target contour prediction model for markerless tumor positioning. Med Phys 2022; 49:1382-1390. [PMID: 35026057 DOI: 10.1002/mp.15456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2021] [Revised: 12/03/2021] [Accepted: 12/28/2021] [Indexed: 11/11/2022] Open
Abstract
PURPOSE For pancreatic cancer patients, image guided radiation therapy and real-time tumor tracking (RTTT) techniques can deliver radiation to the target accurately. Currently, for the radiation therapy machine with kV X-ray imaging systems, internal markers must be implemented to facilitate tumor tracking. The purpose of this study was to develop a markerless deep learning-based pancreatic tumor positioning procedure for real-time tumor tracking with a kV X-ray imaging system. METHODS AND MATERIALS Fourteen pancreatic cancer patients treated with intensity-modulated radiation therapy from six fixed gantry angles with a gimbal-head radiotherapy system were included in this study. For a gimbal-head radiotherapy system, the three-dimensional (3D) intrafraction target position can be determined using an orthogonal kV X-ray imaging system. All patients underwent four-dimensional computed tomography (4DCT) simulations for treatment planning, which were divided into 10 respiratory phases. After a patient's 4DCT was acquired, for each X-ray tube angle, 10 digitally reconstructed radiograph (DRR) images were obtained. Then, a data augmentation procedure was conducted. The data augmentation procedure first rotated the CT volume around the superior-inferior and anterior-posterior directions from -3° to 3° in 1.5° intervals. Then, the Super-SloMo model was adapted to interpolate 10 frames between respiratory phases. In total, the data augmentation procedure expanded the data scale 250-fold. In this study, for each patient, 12 datasets containing the DRR images from each specific X-ray tube angle based on the radiation therapy plan were obtained. The augmented dataset was randomly divided into training and testing datasets. The training dataset contained 2000 DRR images with clinical target volume (CTV) contours labeled for fine-tuning the pre-trained target contour prediction model. After the fine-tuning, the patient and X-ray tube angle-specific CTV contour prediction model was acquired. The testing dataset contained the remaining 500 images to evaluate the performance of the CTV contour prediction model. The dice similarity coefficient (DSC) between the area enclosed by the CTV contour and predicted contour was calculated to evaluate the model's contour prediction performance. The 3D position of the CTV was calculated based on the centroid of the contour in the orthogonal DRR images, and the 3D error of the prediction position was calculated to evaluate the CTV positioning performance. For each patient, the DSC results from 12 X-ray tube angles and 3D error from 6 gantry angles were calculated, representing the novelty of this study. RESULTS The mean and standard deviation (SD) of all patients' DSCs were 0.98 and 0.015, respectively. The mean and SD of the 3D error were 0.29 mm and 0.14 mm, respectively. The global maximum 3D error was 1.66 mm, and the global minimum DSC was 0.81. The mean calculation time for CTV contour prediction was 55 ms per image. This fulfills the requirement of RTTT. CONCLUSIONS Regarding the positioning accuracy and calculation efficiency, the presented procedure can provide a solution for markerless real-time tumor tracking for pancreatic cancer patients. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Dejun Zhou
- Division of Medical Physics, Department of Information Technology and Medical Engineering, Human Health Sciences, Graduate School of Medicine, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan
| | - Mitsuhiro Nakamura
- Division of Medical Physics, Department of Information Technology and Medical Engineering, Human Health Sciences, Graduate School of Medicine, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.,Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan
| | - Nobutaka Mukumoto
- Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan
| | - Michio Yoshimura
- Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan
| | - Takashi Mizowaki
- Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan
| |
Collapse
|
3
|
Kawashima M, Tashiro M, Varnava M, Shiba S, Matsui T, Okazaki S, Li Y, Komatsu S, Kawamura H, Okamoto M, Ohno T. An adaptive planning strategy in carbon ion therapy of pancreatic cancer involving beam angle selection. Phys Imaging Radiat Oncol 2022; 21:35-41. [PMID: 35198743 PMCID: PMC8850338 DOI: 10.1016/j.phro.2022.01.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2021] [Revised: 01/26/2022] [Accepted: 01/26/2022] [Indexed: 11/19/2022] Open
Affiliation(s)
- Motohiro Kawashima
- Gunma University Heavy Ion Medical Center, 3-39-22 Showa-Machi, Maebashi, Gunma, Japan
- Corresponding author at: 3-39-22, Showa-Machi, Maebashi, Gunma 371-8511, Japan.
| | - Mutsumi Tashiro
- Gunma University Heavy Ion Medical Center, 3-39-22 Showa-Machi, Maebashi, Gunma, Japan
| | - Maria Varnava
- Gunma University Heavy Ion Medical Center, 3-39-22 Showa-Machi, Maebashi, Gunma, Japan
| | - Shintaro Shiba
- Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22 Showa-Machi, Maebashi, Gunma, Japan
| | - Toshiaki Matsui
- Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22 Showa-Machi, Maebashi, Gunma, Japan
| | - Shohei Okazaki
- Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22 Showa-Machi, Maebashi, Gunma, Japan
| | - Yang Li
- Gunma University Heavy Ion Medical Center, 3-39-22 Showa-Machi, Maebashi, Gunma, Japan
| | - Shuichiro Komatsu
- Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22 Showa-Machi, Maebashi, Gunma, Japan
| | - Hidemasa Kawamura
- Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22 Showa-Machi, Maebashi, Gunma, Japan
| | - Masahiko Okamoto
- Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22 Showa-Machi, Maebashi, Gunma, Japan
| | - Tatsuya Ohno
- Gunma University Heavy Ion Medical Center, 3-39-22 Showa-Machi, Maebashi, Gunma, Japan
- Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22 Showa-Machi, Maebashi, Gunma, Japan
| |
Collapse
|
4
|
Brunner TB, Haustermans K, Huguet F, Morganti AG, Mukherjee S, Belka C, Krempien R, Hawkins MA, Valentini V, Roeder F. ESTRO ACROP guidelines for target volume definition in pancreatic cancer. Radiother Oncol 2021; 154:60-69. [DOI: 10.1016/j.radonc.2020.07.052] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2020] [Accepted: 07/29/2020] [Indexed: 02/08/2023]
|
5
|
Bertholet J, Knopf A, Eiben B, McClelland J, Grimwood A, Harris E, Menten M, Poulsen P, Nguyen DT, Keall P, Oelfke U. Real-time intrafraction motion monitoring in external beam radiotherapy. Phys Med Biol 2019; 64:15TR01. [PMID: 31226704 PMCID: PMC7655120 DOI: 10.1088/1361-6560/ab2ba8] [Citation(s) in RCA: 116] [Impact Index Per Article: 23.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2019] [Revised: 05/10/2019] [Accepted: 06/21/2019] [Indexed: 12/25/2022]
Abstract
Radiotherapy (RT) aims to deliver a spatially conformal dose of radiation to tumours while maximizing the dose sparing to healthy tissues. However, the internal patient anatomy is constantly moving due to respiratory, cardiac, gastrointestinal and urinary activity. The long term goal of the RT community to 'see what we treat, as we treat' and to act on this information instantaneously has resulted in rapid technological innovation. Specialized treatment machines, such as robotic or gimbal-steered linear accelerators (linac) with in-room imaging suites, have been developed specifically for real-time treatment adaptation. Additional equipment, such as stereoscopic kilovoltage (kV) imaging, ultrasound transducers and electromagnetic transponders, has been developed for intrafraction motion monitoring on conventional linacs. Magnetic resonance imaging (MRI) has been integrated with cobalt treatment units and more recently with linacs. In addition to hardware innovation, software development has played a substantial role in the development of motion monitoring methods based on respiratory motion surrogates and planar kV or Megavoltage (MV) imaging that is available on standard equipped linacs. In this paper, we review and compare the different intrafraction motion monitoring methods proposed in the literature and demonstrated in real-time on clinical data as well as their possible future developments. We then discuss general considerations on validation and quality assurance for clinical implementation. Besides photon RT, particle therapy is increasingly used to treat moving targets. However, transferring motion monitoring technologies from linacs to particle beam lines presents substantial challenges. Lessons learned from the implementation of real-time intrafraction monitoring for photon RT will be used as a basis to discuss the implementation of these methods for particle RT.
Collapse
Affiliation(s)
- Jenny Bertholet
- Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS
Foundation Trust, London, United
Kingdom
- Author to whom any correspondence should be
addressed
| | - Antje Knopf
- Department of Radiation Oncology,
University Medical Center
Groningen, University of Groningen, The
Netherlands
| | - Björn Eiben
- Department of Medical Physics and Biomedical
Engineering, Centre for Medical Image Computing, University College London, London,
United Kingdom
| | - Jamie McClelland
- Department of Medical Physics and Biomedical
Engineering, Centre for Medical Image Computing, University College London, London,
United Kingdom
| | - Alexander Grimwood
- Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS
Foundation Trust, London, United
Kingdom
| | - Emma Harris
- Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS
Foundation Trust, London, United
Kingdom
| | - Martin Menten
- Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS
Foundation Trust, London, United
Kingdom
| | - Per Poulsen
- Department of Oncology, Aarhus University Hospital, Aarhus,
Denmark
| | - Doan Trang Nguyen
- ACRF Image X Institute, University of Sydney, Sydney,
Australia
- School of Biomedical Engineering,
University of Technology
Sydney, Sydney, Australia
| | - Paul Keall
- ACRF Image X Institute, University of Sydney, Sydney,
Australia
| | - Uwe Oelfke
- Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS
Foundation Trust, London, United
Kingdom
| |
Collapse
|
6
|
Zhao W, Shen L, Han B, Yang Y, Cheng K, Toesca DAS, Koong AC, Chang DT, Xing L. Markerless Pancreatic Tumor Target Localization Enabled By Deep Learning. Int J Radiat Oncol Biol Phys 2019; 105:432-439. [PMID: 31201892 DOI: 10.1016/j.ijrobp.2019.05.071] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2018] [Revised: 05/17/2019] [Accepted: 05/25/2019] [Indexed: 02/07/2023]
Abstract
PURPOSE Deep learning is an emerging technique that allows us to capture imaging information beyond the visually recognizable level of a human being. Because of the anatomic characteristics and location, on-board target verification for radiation delivery to pancreatic tumors is a challenging task. Our goal was to use a deep neural network to localize the pancreatic tumor target on kV x-ray images acquired using an on-board imager for image guided radiation therapy. METHODS AND MATERIALS The network is set up in such a way that the input is either a digitally reconstructed radiograph image or a monoscopic x-ray projection image acquired by the on-board imager from a given direction, and the output is the location of the planning target volume in the projection image. To produce a sufficient number of training x-ray images reflecting the vast number of possible clinical scenarios of anatomy distribution, a series of changes were introduced to the planning computed tomography images, including deformation, rotation, and translation, to simulate inter- and intrafractional variations. After model training, the accuracy of the model was evaluated by retrospectively studying patients who underwent pancreatic cancer radiation therapy. Statistical analysis using mean absolute differences (MADs) and Lin's concordance correlation coefficient were used to assess the accuracy of the predicted target positions. RESULTS MADs between the model-predicted and the actual positions were found to be less than 2.60 mm in anteroposterior, lateral, and oblique directions for both axes in the detector plane. For comparison studies with and without fiducials, MADs are less than 2.49 mm. For all cases, Lin's concordance correlation coefficients between the predicted and actual positions were found to be better than 93%, demonstrating the success of the proposed deep learning for image guided radiation therapy. CONCLUSIONS We demonstrated that markerless pancreatic tumor target localization is achievable with high accuracy by using a deep learning technique approach.
Collapse
Affiliation(s)
- Wei Zhao
- Department of Radiation Oncology, Stanford University, Stanford, California
| | - Liyue Shen
- Department of Radiation Oncology, Stanford University, Stanford, California
| | - Bin Han
- Department of Radiation Oncology, Stanford University, Stanford, California
| | - Yong Yang
- Department of Radiation Oncology, Stanford University, Stanford, California
| | - Kai Cheng
- Department of Radiation Oncology, Stanford University, Stanford, California
| | - Diego A S Toesca
- Department of Radiation Oncology, Stanford University, Stanford, California
| | - Albert C Koong
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Daniel T Chang
- Department of Radiation Oncology, Stanford University, Stanford, California
| | - Lei Xing
- Department of Radiation Oncology, Stanford University, Stanford, California.
| |
Collapse
|
7
|
Vogel L, Sihono DSK, Weiss C, Lohr F, Stieler F, Wertz H, von Swietochowski S, Simeonova-Chergou A, Wenz F, Blessing M, Boda-Heggemann J. Intra-breath-hold residual motion of image-guided DIBH liver-SBRT: An estimation by ultrasound-based monitoring correlated with diaphragm position in CBCT. Radiother Oncol 2018; 129:441-448. [DOI: 10.1016/j.radonc.2018.07.007] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2018] [Revised: 07/04/2018] [Accepted: 07/06/2018] [Indexed: 10/28/2022]
|
8
|
Patch SK, Santiago-Gonzalez D, Mustapha B. Thermoacoustic range verification in the presence of acoustic heterogeneity and soundspeed errors - Robustness relative to ultrasound image of underlying anatomy. Med Phys 2018; 46:318-327. [PMID: 30362132 DOI: 10.1002/mp.13256] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2018] [Revised: 09/11/2018] [Accepted: 10/12/2018] [Indexed: 11/07/2022] Open
Abstract
PURPOSE To demonstrate robustness of thermooacoustic range verification to acoustic heterogeneity and discrepancies between assumed and true propagation speed, i.e., soundspeed errors. METHODS A beam sweeper was used to deliver 250 ns pulses that deposited 0.26 Gy of 16 MeV protons and 2.3 Gy of 60 MeV helium ions into water and oil targets, respectively. Thermoacoustic signals were detected by a 96-channel ultrasound array with a 1-4 MHz sensitivity band (-6 dB), bandpass filtered and backprojected to create thermoacoustic images in the plane of the ultrasound array. The same soundspeed and transducer array were used to estimate range and generate the ultrasound images onto which Bragg peak locations were overlaid. An air-gap phantom that displaced the Bragg peak by 6.5 mm demonstrated accuracy. Robustness to soundspeed errors was demonstrated in a waterbath as the assumed propagation speed scanner setting was altered by ± 5 % . Tissue-mimicking gelatin and a bone sample were introduced to demonstrate robustness to acoustic heterogeneity relative to ultrasound images of the underlying morphology. RESULTS Single ion pulse measurements sufficed during the helium run, but signal averaging was required for protons. Range and entry point into the target were estimated from data collected by transducers placed at least 6 cm distal to the Bragg peak. When ultrasound images depicted the air-target interface where the beam enters, estimates of the entry point agreed with ultrasound images and range estimates agreed with Monte Carlo simulations to within 300 μm, even when thermoacoustic emissions traveled through a strongly scattering bone sample. Estimated Bragg peak locations were translated 6.5 mm by the air-gap phantom and correctly identified scenarios when the beam stopped inside the bone. CONCLUSIONS Soundspeed errors dilate and acoustic heterogeneities deform ultrasound images. When thermoacoustic receivers are co-located with the ultrasound imaging array, the same transformations shift thermoacoustic range estimates. Therefore, thermoacoustic range verification is robust relative to ultrasound images of underlying anatomy. When the treatment target is visible in ultrasound, e.g., prostate, online thermoacoustic range estimates could verify that the treatment spot is inside the target.
Collapse
Affiliation(s)
- Sarah K Patch
- Department of Physics, UW-Milwaukee, PO Box 413, Milwaukee, WI, 53201, USA
| | | | - Brahim Mustapha
- Physics Division, Argonne National Laboratory, Argonne, IL, 60439, USA
| |
Collapse
|
9
|
De Luca V, Banerjee J, Hallack A, Kondo S, Makhinya M, Nouri D, Royer L, Cifor A, Dardenne G, Goksel O, Gooding MJ, Klink C, Krupa A, Le Bras A, Marchal M, Moelker A, Niessen WJ, Papiez BW, Rothberg A, Schnabel J, van Walsum T, Harris E, Lediju Bell MA, Tanner C. Evaluation of 2D and 3D ultrasound tracking algorithms and impact on ultrasound-guided liver radiotherapy margins. Med Phys 2018; 45:4986-5003. [PMID: 30168159 DOI: 10.1002/mp.13152] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2018] [Revised: 07/26/2018] [Accepted: 07/27/2018] [Indexed: 12/25/2022] Open
Abstract
PURPOSE Compensation for respiratory motion is important during abdominal cancer treatments. In this work we report the results of the 2015 MICCAI Challenge on Liver Ultrasound Tracking and extend the 2D results to relate them to clinical relevance in form of reducing treatment margins and hence sparing healthy tissues, while maintaining full duty cycle. METHODS We describe methodologies for estimating and temporally predicting respiratory liver motion from continuous ultrasound imaging, used during ultrasound-guided radiation therapy. Furthermore, we investigated the trade-off between tracking accuracy and runtime in combination with temporal prediction strategies and their impact on treatment margins. RESULTS Based on 2D ultrasound sequences from 39 volunteers, a mean tracking accuracy of 0.9 mm was achieved when combining the results from the 4 challenge submissions (1.2 to 3.3 mm). The two submissions for the 3D sequences from 14 volunteers provided mean accuracies of 1.7 and 1.8 mm. In combination with temporal prediction, using the faster (41 vs 228 ms) but less accurate (1.4 vs 0.9 mm) tracking method resulted in substantially reduced treatment margins (70% vs 39%) in contrast to mid-ventilation margins, as it avoided non-linear temporal prediction by keeping the treatment system latency low (150 vs 400 ms). Acceleration of the best tracking method would improve the margin reduction to 75%. CONCLUSIONS Liver motion estimation and prediction during free-breathing from 2D ultrasound images can substantially reduce the in-plane motion uncertainty and hence treatment margins. Employing an accurate tracking method while avoiding non-linear temporal prediction would be favorable. This approach has the potential to shorten treatment time compared to breath-hold and gated approaches, and increase treatment efficiency and safety.
Collapse
Affiliation(s)
- Valeria De Luca
- Computer Vision Laboratory, ETH Zurich, Zürich, Switzerland
- Novartis Institutes for Biomedical Research, Basel, Switzerland
| | | | - Andre Hallack
- Institute of Biomedical Engineering, University of Oxford, Oxford, UK
| | | | - Maxim Makhinya
- Computer Vision Laboratory, ETH Zurich, Zürich, Switzerland
| | | | - Lucas Royer
- Institut de Recherche Technologique b-com, Rennes, France
| | | | | | - Orcun Goksel
- Computer Vision Laboratory, ETH Zurich, Zürich, Switzerland
| | | | - Camiel Klink
- Department of Radiology, Erasmus MC, Rotterdam, The Netherlands
| | | | | | - Maud Marchal
- Institut de Recherche Technologique b-com, Rennes, France
| | - Adriaan Moelker
- Department of Radiology, Erasmus MC, Rotterdam, The Netherlands
| | - Wiro J Niessen
- Department of Radiology, Erasmus MC, Rotterdam, The Netherlands
| | | | | | - Julia Schnabel
- School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK
| | - Theo van Walsum
- Department of Radiology, Erasmus MC, Rotterdam, The Netherlands
| | | | - Muyinatu A Lediju Bell
- Department of Electrical and Computer Engineering, Johns Hopkins University, Baltimore, USA
| | | |
Collapse
|
10
|
Mostafaei F, Tai A, Gore E, Johnstone C, Haase W, Ehlers C, Cooper DT, Lachaine M, Li XA. Feasibility of real-time lung tumor motion monitoring using intrafractional ultrasound and kV cone beam projection images. Med Phys 2018; 45:4619-4626. [DOI: 10.1002/mp.13104] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2018] [Revised: 07/13/2018] [Accepted: 07/18/2018] [Indexed: 11/08/2022] Open
Affiliation(s)
- Farshad Mostafaei
- Department of Radiation Oncology; Medical College of Wisconsin; Milwaukee WI 53226 USA
| | - An Tai
- Department of Radiation Oncology; Medical College of Wisconsin; Milwaukee WI 53226 USA
| | - Elizabeth Gore
- Department of Radiation Oncology; Medical College of Wisconsin; Milwaukee WI 53226 USA
| | - Candice Johnstone
- Department of Radiation Oncology; Medical College of Wisconsin; Milwaukee WI 53226 USA
| | - William Haase
- Department of Radiation Oncology; Medical College of Wisconsin; Milwaukee WI 53226 USA
| | - Christopher Ehlers
- Department of Radiology; Medical College of Wisconsin; Milwaukee WI 53226 USA
| | | | | | - X. Allen Li
- Department of Radiation Oncology; Medical College of Wisconsin; Milwaukee WI 53226 USA
| |
Collapse
|
11
|
Hickling S, Xiang L, Jones KC, Parodi K, Assmann W, Avery S, Hobson M, El Naqa I. Ionizing radiation‐induced acoustics for radiotherapy and diagnostic radiology applications. Med Phys 2018; 45:e707-e721. [DOI: 10.1002/mp.12929] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2017] [Revised: 02/20/2018] [Accepted: 04/09/2017] [Indexed: 01/29/2023] Open
Affiliation(s)
- Susannah Hickling
- Department of Physics & Medical Physics Unit McGill University 1001 boul Decarie Montreal QC H4A 3J1Canada
| | - Liangzhong Xiang
- School of Electrical and Computer Engineering University of Oklahoma Norman OK 73019USA
| | - Kevin C. Jones
- Department of Radiation Oncology Rush University Medical Center Chicago IL 60612USA
| | - Katia Parodi
- Department of Medical Physics Ludwig‐Maximilians‐Universität Garching b. München 85748Germany
| | - Walter Assmann
- Department of Medical Physics Ludwig‐Maximilians‐Universität Garching b. München 85748Germany
| | - Stephen Avery
- Department of Radiation Oncology University of Pennsylvania Philadelphia PA19104USA
| | - Maritza Hobson
- Medical Physics Unit McGill University Health Centre Montreal QC H4A 3J1Canada
- Department of Oncology Department of Physics & Medical Physics Unit McGill University Montreal QC H4A 3J1Canada
| | - Issam El Naqa
- Department of Radiation Oncology University of Michigan Ann Arbor MI 48103‐4943USA
| |
Collapse
|
12
|
Shibata S, Takamatsu S, Yamamoto K, Mizuhata M, Bou S, Sato Y, Kawamura M, Asahi S, Tameshige Y, Maeda Y, Sasaki M, Kumano T, Kobayashi S, Tamamura H, Gabata T. Proton Beam Therapy without Fiducial Markers Using Four-Dimensional CT Planning for Large Hepatocellular Carcinomas. Cancers (Basel) 2018; 10:E71. [PMID: 29538310 PMCID: PMC5876646 DOI: 10.3390/cancers10030071] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2018] [Revised: 03/07/2018] [Accepted: 03/12/2018] [Indexed: 02/06/2023] Open
Abstract
We evaluated the effectiveness and toxicity of proton beam therapy (PBT) for hepatocellular carcinomas (HCC) >5 cm without fiducial markers using four-dimensional CT (4D-CT) planning. The subjects were 29 patients treated at our hospital between March 2011 and March 2015. The median total dose was 76 Cobalt Gray Equivalents (CGE) in 20 fractions (range; 66-80.5 CGE in 10-32 fractions). Therapy was delivered with end-expiratory phase gating. An internal target volume (ITV) margin was added through the analysis of respiratory movement with 4D-CT. Patient age ranged from 38 to 87 years (median, 71 years). Twenty-four patients were Child-Pugh class A and five patients were class B. Tumor size ranged from 5.0 to 13.9 cm (median, 6.9 cm). The follow-up period ranged from 2 to 72 months (median; 27 months). All patients completed PBT according to the treatment protocol without grade 4 (CTCAE v4.03 (draft v5.0)) or higher adverse effects. The two-year local tumor control (LTC), progression-free survival (PFS), and overall survival (OS) rates were 95%, 22%, and 61%, respectively. The LTC was not inferior to that of previous reports using fiducial markers. Respiratory-gated PBT with 4D-CT planning without fiducial markers is a less invasive and equally effective treatment for large HCCs as PBT with fiducial markers.
Collapse
Affiliation(s)
- Satoshi Shibata
- Proton Therapy Center, Fukui Prefectural Hospital, Fukui 910-8526, Japan.
| | - Shigeyuki Takamatsu
- Proton Therapy Center, Fukui Prefectural Hospital, Fukui 910-8526, Japan.
- Department of Radiotherapy, Kanazawa University Hospital, Kanazawa, Ishikawa 920-8641, Japan.
| | - Kazutaka Yamamoto
- Proton Therapy Center, Fukui Prefectural Hospital, Fukui 910-8526, Japan.
| | - Miu Mizuhata
- Proton Therapy Center, Fukui Prefectural Hospital, Fukui 910-8526, Japan.
| | - Sayuri Bou
- Proton Therapy Center, Fukui Prefectural Hospital, Fukui 910-8526, Japan.
| | - Yoshitaka Sato
- Proton Therapy Center, Fukui Prefectural Hospital, Fukui 910-8526, Japan.
| | - Mariko Kawamura
- Department of Radiology, Nagoya University Hospital, Nagoya, Aichi 466-8560, Japan.
| | - Satoko Asahi
- Department of Radiology, University of Fukui Hospital, Eiheiji, Fukui 910-1193, Japan.
| | - Yuji Tameshige
- Proton Therapy Center, Fukui Prefectural Hospital, Fukui 910-8526, Japan.
| | - Yoshikazu Maeda
- Proton Therapy Center, Fukui Prefectural Hospital, Fukui 910-8526, Japan.
| | - Makoto Sasaki
- Proton Therapy Center, Fukui Prefectural Hospital, Fukui 910-8526, Japan.
| | - Tomoyasu Kumano
- Department of Radiotherapy, Kanazawa University Hospital, Kanazawa, Ishikawa 920-8641, Japan.
| | - Satoshi Kobayashi
- Department of Radiology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa 920-8641, Japan.
| | - Hiroyasu Tamamura
- Proton Therapy Center, Fukui Prefectural Hospital, Fukui 910-8526, Japan.
| | - Toshifumi Gabata
- Department of Radiology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa 920-8641, Japan.
| |
Collapse
|
13
|
Liang Z, Liu H, Xue J, Hu B, Zhu B, Li Q, Zhang S, Wu G. Evaluation of the intra- and interfractional tumor motion and variability by fiducial-based real-time tracking in liver stereotactic body radiation therapy. J Appl Clin Med Phys 2018; 19:94-100. [PMID: 29493095 PMCID: PMC5978939 DOI: 10.1002/acm2.12292] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2017] [Revised: 01/16/2018] [Accepted: 01/22/2018] [Indexed: 12/25/2022] Open
Abstract
PURPOSE Tumor motion amplitude varies during treatment. The purpose of the study was to evaluate the intra- and interfraction tumor motion and variability in patients with liver cancer treated with fiducial-based real-time tracking stereotactic body radiotherapy (SBRT). METHODS Fourteen liver patients were treated with SBRT using a CyberKnife. Two to four fiducial markers implanted near the tumor were used for real-time monitoring using the Synchrony system. The tumor motion information during treatment was extracted from the log files recorded by the Synchrony system. Logfile-based amplitudes in the superior-posterior (SI), left-right (LR) and anterior-posterior (AP) directions were compared to the 4DCT-based amplitudes. The intra- and interfraction amplitude variations and the incidence of baseline shifts were analyzed for 66 fractions administered to 14 patients. RESULTS The median (range) logfile-based liver motion amplitudes for all patients were 11.9 (5.1-17.3) mm, 1.3 (0.4-4) mm and 3.8 (0.9-7.7) mm in the SI, LR and AP directions, respectively. Compared with the logfile-based amplitude, the 4DCT-based amplitude was underestimated (P < 0.05). The median (range) intra- and interfraction liver motion amplitude variations were 4.3 (1.6-6.0) mm (SI), 0.5 (0.2-2.2) mm(LR) and 1.5 (0.3-3.3) mm (AP) and 1.7 (0.5-4.6) mm (SI), 0.3 (0.1-3.0) mm (LR) and 0.7 (0.3-2.7) mm (AP), respectively. Baseline shifts exceeding 2 mm, 3 mm and 5 mm were observed in 27.3%, 7.6% and 3% of the measurements, respectively, within 10 min, and in 66.7%, 38.1% and 19%, respectively, within 30 min for the square root of the sum of the squares of the distances in the SI, LR and AP directions (3D). The tumor motion amplitude was found to be correlated with the baseline shift. CONCLUSIONS Most patients showed significant intra- and interfraction liver motion amplitude variations over the entire course of radiation. More caution is needed for patients with large tumor motion amplitudes.
Collapse
Affiliation(s)
- Zhiwen Liang
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Hongyuan Liu
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Jun Xue
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Bin Hu
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Bin Zhu
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Qin Li
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Sheng Zhang
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Gang Wu
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| |
Collapse
|
14
|
Martyn M, O'Shea TP, Harris E, Bamber J, Gilroy S, Foley MJ. A Monte Carlo study of the effect of an ultrasound transducer on surface dose during intrafraction motion imaging for external beam radiation therapy. Med Phys 2017; 44:5020-5033. [PMID: 28688115 DOI: 10.1002/mp.12464] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2017] [Revised: 06/19/2017] [Accepted: 07/04/2017] [Indexed: 12/21/2022] Open
Abstract
PURPOSE The aim of this study was to estimate changes in surface dose due to the presence of the Clarity Autoscan™ ultrasound (US) probe during prostate radiotherapy using Monte Carlo (MC) methods. METHODS MC models of the Autoscan US probe were developed using the BEAMnrc/DOSXYZnrc code based on kV and MV CT images. CT datasets were converted to voxelized mass density phantoms using a CT number-to-mass density calibration. The dosimetric effect of the probe, in the contact region (an 8 mm × 12 mm single layer of voxels), was investigated using a phantom set-up mimicking two scenarios (a) a transperineal imaging configuration (radiation beam perpendicular to the central US axial direction), and (b) a transabdominal imaging configuration (radiation beam parallel to the central US axial direction). For scenario (a), the dosimetric effect was evaluated as a function of the probe to inferior radiation field edge distance. Clinically applicable distances from 5 mm separation to 2 mm overlap were determined from the radiotherapy plans of 27 patients receiving Clarity imaging. Overlaps of 3 to 14 (1 to 3 SD) mm were also considered to include the effect of interfraction motion correction. The influence of voxel size on surface dose estimation was investigated. Approved clinical plans from two prostate patients were used to simulate worst-case dosimetric impact of the probe when large couch translations were applied to correct for interfraction prostate motion. RESULTS The dosimetric impact of both the MV and kV probe models agreed within ±2% for both beam configurations. For scenario (a) and 1 mm voxel model, the probe gave mean dose increases of 1.2% to 4.6% (of the dose at isocenter) for 5 mm separation to 0 mm overlap in the probe-phantom contact region, respectively. This increased to 27.5% for the largest interfraction motion correction considered (14 mm overlap). For separations of ≥ 2 mm dose differences were < 2%. Simulated dose perturbations were found to be superficial; for the 14 mm overlap the dose increase reduced to < 3% at 5.0 mm within the phantom. For scenario (b), dose increases due to the probe were < 5% in all cases. The dose increase was underestimated by up to ~13% when the voxel size was increased from 1 mm to 3 mm. MC simulated dose to the PTV and OARs for the two clinical plans considered showed good agreement with commercial treatment planning system results (within 2%). Mean dose increases due to the presence of the probe, after the maximum interfraction motion correction, were ~16.3% and ~8.0%, in the contact region, for plan 1 and plan 2, respectively. CONCLUSIONS The presence of the probe results in superficial dose perturbations for patients with an overlap between the probe and the radiation field present in either the original treatment plan or due to translation of the radiation field to simulate correction of interfraction internal prostate motion.
Collapse
Affiliation(s)
- Michael Martyn
- School of Physics, National University of Ireland Galway, University Road, Galway, Ireland
| | - Tuathan P O'Shea
- Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK
| | - Emma Harris
- Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK
| | - Jeffrey Bamber
- Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK
| | - Stephen Gilroy
- Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK
| | - Mark J Foley
- School of Physics, National University of Ireland Galway, University Road, Galway, Ireland
| |
Collapse
|